SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Grigsby PW,Dehdashti F,Siegel BA. FDG-PET evaluation of carcinoma of the cervix. Clin Pos Imaging. 1999; 2: 105109.
  • 2
    Grigsby PW,Siegel BA,Dehdashti F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol. 2001; 19: 37453749.
  • 3
    Grigsby PW,Siegel BA,Dehdashti F, et al. Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. J Clin Oncol. 2004; 22: 21672171.
  • 4
    Miller TR,Grigsby PW. Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy. Int J Radiat Oncol Biol Phys. 2002; 53: 353359.
  • 5
    Miller TR,Pinkus E,Dehdashti F, et al. Improved prognostic value of 18F-FDG PET using a simple visual analysis of tumor characteristics in patients with cervical cancer. J Nucl Med. 2003; 44: 192197.
  • 6
    Rose PG,Adler LP,Rodriguez M, et al. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. J Clin Oncol. 1999; 17: 4145.
  • 7
    Wong TZ,Jones EL,Coleman RE. Positron emission tomography with 2-deoxy-2-[(18)F]fluoro-D-glucose for evaluating local and distant disease in patients with cervical cancer. Mol Imaging Biol. 2004; 6: 5562.
  • 8
    Allal AS,Slosman DO,Kebdani T, et al. Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose. Int J Radiat Oncol Biol Phys. 2004; 59: 12951300.
  • 9
    Borst GR,Belderbos JS,Boellaard R, et al. Standardised FDG uptake: a prognostic factor for inoperable non-small cell lung cancer. Eur J Cancer. 2005; 41: 15331541.
  • 10
    Downey RJ,Akhurst T,Gonen M, et al. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol. 2004; 22: 32553260.
  • 11
    Eschmann SM,Friedel G,Paulsen F, et al. Is standardised (18)F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer? Eur J Nucl Med Mol Imaging. 2006; 33: 263269.
  • 12
    Kieninger AN,Welsh R,Bendick PJ, et al. Positron-emission tomography as a prognostic tool for early-stage lung cancer. Am J Surg. 2006; 191: 433436.
  • 13
    Sasaki R,Komaki R,Macapinlac H, et al. [18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer. J Clin Oncol. 2005; 23: 11361143.
  • 14
    Schwartz DL,Rajendran J,Yueh B, et al. FDG-PET prediction of head and neck squamous cell cancer out-comes. Arch Otolaryngol Head Neck Surg. 2004; 130: 13611367.
  • 15
    Vansteenkiste JF,Stroobants SG,Dupont PJ, et al. Prognostic importance of the standardized uptake value on 18F-fluoro-2-deoxy-glucose–positron emission tomography scan in non–small-cell lung cancer: an analysis of 125 cases. J Clin Oncol. 1999; 17: 32013206.
  • 16
    Xue F,Lin LL,Dehdashti F, et al. F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy. Gynecol Oncol. 2006; 101: 147151.
  • 17
    Perez CA,Kavanagh BD. Uterine cervix. In: PerezCA,BradyLW,HalperinEC, et al., editors. Principles and Practice of Radiation Oncology.4th ed. Philadelphia: Lippincott, Williams & Williams; 2003: 18001915.
  • 18
    Wright JD,Dehdashti F,Herzog TJ, et al. Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography. Cancer. 2005; 104: 24842491.
  • 19
    Cox DR. Regression models and life tables. J R Stat Soc. 1972; 34: 187220.
  • 20
    Kaplan EL,Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53: 457481.
  • 21
    Perez CA,Grigsby PW,Chao KSC, et al. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix. Int J Radiat Oncol Biol Phys. 1998; 41: 307317.
  • 22
    Delgado G,Bundy BN,Fowler WCJr, et al. A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study. Gynecol Oncol. 1989; 35: 314320.
  • 23
    Leveque J,Laurent JF,Burtin F, et al. Prognostic factors of the uterine cervix adenocarcinoma. Eur J Obstet Gynecol Reprod Biol. 1998; 80: 209214.
  • 24
    Chen RJ,Chang DY,Yen ML, et al. Prognostic factors of primary adenocarcinoma of the uterine cervix. Gynecol Oncol. 1998; 69: 157164.
  • 25
    Pillot G,Siegel BA,Govindan R. Prognostic significance of fluorodeoxyglucose positron emission tomography in non-small cell lung cancer: a review. J Thorac Oncol. 2006; 1: 152159.
  • 26
    Sachs S,Bilfinger TV,Komaroff E, et al. Increased standardized uptake value in the primary lesion predicts nodal or distant metastases at presentation in lung cancer. Clin Lung Cancer. 2005; 6: 310313.
  • 27
    Hardt N,van Nagell JR,Hanson M, et al. Radiation-induced tumor regression as a prognostic factor in patients with invasive cervical cancer. Cancer. 1982; 49: 3539.
  • 28
    Hong JH,Chen MS,Lin FJ, et al. Prognostic assessment of tumor regression after external irradiation for cervical cancer. Int J Radiat Oncol Biol Phys. 1992; 22: 913917.
  • 29
    Lin LL,Yang Z,Mutic S, et al. FDG-PET imaging for the assessment of physiologic volume response during radiotherapy in cervix cancer. Int J Radiat Oncol Biol Phys. 2006; 65: 177181.
  • 30
    Brown RS,Goodman TM,Zasadny KR, et al. Expression of hexokinase II and Glut-1 in untreated human breast cancer. Nucl Med Biol. 2002; 29: 443453.
  • 31
    Avril N,Menzel M,Dose J, et al. Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis. J Nucl Med. 2001; 42: 916.
  • 32
    Mendez LE,Manci N,Cantuaria G, et al. Expression of glucose transporter-1 in cervical cancer and its precursors. Gynecol Oncol. 2002; 86: 138143.
  • 33
    Airley R,Loncaster J,Davidson S, et al. Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clin Cancer Res. 2001; 7: 928934.
  • 34
    Yen T-C,See L-C,Lai C-H, et al. 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression. J Nucl Med. 2004; 45: 2229.
  • 35
    Tian M,Zhang H,Nakasone Y,Mogi K,Endo K. Eur J Nucl Med Mol Imaging. 2004; 31: 512.